Withdrawn as duplicate: Evaluation of discharge prescribing after rescheduling of gabapentin as a controlled substance.

Robbins, Melody J; Floroff, Catherine; Ingemi, Amanda; Kaplan, Marcus C

Robbins, Melody J; Floroff, Catherine; Ingemi, Amanda; Kaplan, Marcus C.

Robbins MJ; Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA, USA.
Floroff C; Department of Pharmacy, Chesapeake Regional Medical Center, Chesapeake, VA, USA.
Ingemi A; Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA, USA.
Kaplan MC; Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA, USA.

Am J Health Syst Pharm ; 79(8): e97, 2022 04 01.

Article in English | MEDLINE | ID: covidwho-1309588

ABSTRACT

ABSTRACT

This article has been withdrawn due to a publisher error that caused the article to be duplicated. The definitive version of this article is published under DOI 10.1093/ajhp/zxab293.

Subject(s)

Controlled Substances; Patient Discharge; Analgesics, Opioid/therapeutic use; Drug Prescriptions; Gabapentin; Humans; Hydrocodone; Practice Patterns, Physicians'

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Discharge / Controlled Substances Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Am J Health Syst Pharm Journal subject: Pharmacy / Hospitals Year: 2022 Document Type: Article Affiliation country: Ajhp

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google